Cardiovascular risks associated with calcium supplementation in patients with osteoporosis: a nationwide cohort study.

Abstract

AIMS\nThis study aimed to evaluate the real effects of calcium supplementation on cardiovascular outcomes within a population-based cohort.\n\n\nMETHODS AND RESULTS\nFrom a nationwide health screening database in Korea, a total of 11,297 patients with osteoporosis who had taken calcium supplementation with or without vitamin D for at least 90 days (total-calcium group; calcium supplementation only [CaO], n\xa0=\xa0567; calcium supplementation in combination with vitamin D [CaD], n\xa0=\xa010,730) were matched at a 1:1 ratio to patients who had not taken calcium supplements (control group) by using propensity scores. The overall mean age was 59.9\xa0±\xa08.8 years and the percentage of women was 87.9% in our study population. Over a median follow-up of 54 months, the incidence rate of composite cardiovascular diseases (CVD) per 1000 person-years was not different between the groups: 9.73 in the total-calcium group and 8.97 in the control group (adjusted hazard ratio [HR]: 1.12; 95% confidence interval [CI]: 0.99 to 1.28; P\xa0=\xa00.08). However, calcium supplementation without vitamin D was associated with an increased risk of composite CVD (HR: 1.54; 95% CI: 1.17 to 2.04; P\xa0<\xa00.01), especially non-fatal myocardial infarction (HR:1.89; 95% CI: 1.23 to 2.91; P\xa0<\xa00.01), compared with no calcium supplementation.\n\n\nCONCLUSION\nOur population-based study supported that taking calcium supplementation with vitamin D together did not appear to be harmful to cardiovascular health, but reminding that calcium supplementation without vitamin D should be used carefully even in populations with low dietary calcium intake.